Current research into cancer drugs
Help beat cancer sooner
Our life-saving work relies on the money you give us.
Donate now and together we can save more lives by beating cancer sooner.
Saving lives through our research
From the underpinning research that can lead to new treatments, to developing drugs for patients, our researchers are working hard to find new ways to tackle cancer. Below are some examples of what our researchers are doing right now.
Our current researchers
In Cambridge, Professor Tim Eisen is developing and testing new treatments for kidney cancer. He is currently running a large clinical trial called SORCE, to find out whether giving people with kidney cancer a new drug called sorafenib (Nexavar) after they’ve had surgery can improve survival.
Testing PARP inhibitors
Making drugs 'do what it says on the tin'
Dr Udai Banerji in London is involved in many stages of developing new cancer drugs, from working in early drug discovery to designing clinical trials to test new treatments. He's focussed on making sure that a cancer drug acts in the way it's intended to and ‘does what it says on the tin’. This research helps to tailor drug doses. He also works to help find new combinations of cancer drugs that are needed to fight the disease.
On the path of TRAIL
Professor Henning Walczak in London is working to target a cell death pathway triggered by a molecule in cells called TRAIL. He's investigating if targeting molecules in the pathway could work as a treatment for certain cancers where the TRAIL pathway is faulty. This could lead to the development of new treatments for people with these cancers.